- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/14 - Peptides containing saccharide radicals; Derivatives thereof
Patent holdings for IPC class A61K 38/14
Total number of patents in this class: 987
10-year publication summary
|
89
|
107
|
107
|
96
|
97
|
103
|
101
|
87
|
77
|
27
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Yeda Research and Development Co. Ltd. | 1266 |
15 |
| The Regents of the University of California | 18943 |
14 |
| Xellia Pharmaceuticals ApS | 114 |
12 |
| Melinta Therapeutics, Inc. | 60 |
11 |
| Purdue Research Foundation | 3277 |
10 |
| Insmed Incorporated | 207 |
10 |
| Azurity Pharmaceuticals, Inc. | 147 |
10 |
| Theriva Biologics, Inc. | 81 |
10 |
| Protokinetix, Inc. | 17 |
9 |
| The Scripps Research Institute | 1364 |
9 |
| City of Hope | 943 |
8 |
| Immunomedics, Inc. | 290 |
8 |
| Northwestern University | 3112 |
7 |
| Salix Pharmaceuticals, Inc. | 90 |
7 |
| University of Memphis Research Foundation | 112 |
7 |
| ContraFect Corporation | 91 |
7 |
| Centre National de La Recherche Scientifique | 9632 |
6 |
| Massachusetts Institute of Technology | 9795 |
6 |
| Cedars-Sinai Medical Center | 1088 |
6 |
| The Trustees of Princeton University | 1129 |
6 |
| Other owners | 809 |